慢性血栓栓塞性肺动脉高压:全面回顾发病机制、诊断和治疗策略。

IF 1.6 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Revista Portuguesa De Cardiologia Pub Date : 2024-06-28 DOI:10.1016/j.repc.2024.04.006
Daniel Inácio Cazeiro, Miguel Azaredo Raposo, Tatiana Guimarães, Nuno Lousada, David Jenkins, João R Inácio, Susana Moreira, Ana Mineiro, Céline Freitas, Susana Martins, Ricardo Ferreira, Rita Luís, Nuno Cardim, Fausto J Pinto, Rui Plácido
{"title":"慢性血栓栓塞性肺动脉高压:全面回顾发病机制、诊断和治疗策略。","authors":"Daniel Inácio Cazeiro, Miguel Azaredo Raposo, Tatiana Guimarães, Nuno Lousada, David Jenkins, João R Inácio, Susana Moreira, Ana Mineiro, Céline Freitas, Susana Martins, Ricardo Ferreira, Rita Luís, Nuno Cardim, Fausto J Pinto, Rui Plácido","doi":"10.1016/j.repc.2024.04.006","DOIUrl":null,"url":null,"abstract":"<p><p>Chronic thromboembolic pulmonary hypertension (CTEPH) is part of group 4 of the pulmonary hypertension (PH) classification and generally affects more than a third of patients referred to PH centers. It is a three-compartment disease involving proximal (lobar-to-segmental) and distal (subsegmental) pulmonary arteries that are obstructed by persistent fibrothrombotic material, and precapillary pulmonary arteries that can be affected as in pulmonary arterial hypertension. It is a rare complication of pulmonary embolism (PE), with an incidence of around 3% in PE survivors. The observed incidence of CTEPH in the general population is around six cases per million but could be three times higher than this, as estimated from PE incidence. However, a previous venous thromboembolic episode is not always documented. With advances in multimodality imaging and therapeutic management, survival for CTEPH has improved for both operable and inoperable patients. Advanced imaging with pulmonary angiography helps distinguish proximal from distal obstructive disease. However, right heart catheterization is of utmost importance to establish the diagnosis and hemodynamic severity of PH. The therapeutic strategy relies on a stepwise approach, starting with an operability assessment. Pulmonary endarterectomy (PEA), also known as pulmonary thromboendarterectomy, is the first-line treatment for operable patients. Growing experience and advances in surgical technique have enabled expansion of the distal limits of PEA and significant improvements in perioperative and mid- to long-term mortality. In patients who are inoperable or who have persistent/recurrent PH after PEA, medical therapy and/or balloon pulmonary angioplasty (BPA) are effective treatment options with favorable outcomes that are increasingly used. All treatment decisions should be made with a multidisciplinary team that includes a PEA surgeon, a BPA expert, and a chest radiologist.</p>","PeriodicalId":48985,"journal":{"name":"Revista Portuguesa De Cardiologia","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chronic thromboembolic pulmonary hypertension: A comprehensive review of pathogenesis, diagnosis, and treatment strategies.\",\"authors\":\"Daniel Inácio Cazeiro, Miguel Azaredo Raposo, Tatiana Guimarães, Nuno Lousada, David Jenkins, João R Inácio, Susana Moreira, Ana Mineiro, Céline Freitas, Susana Martins, Ricardo Ferreira, Rita Luís, Nuno Cardim, Fausto J Pinto, Rui Plácido\",\"doi\":\"10.1016/j.repc.2024.04.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Chronic thromboembolic pulmonary hypertension (CTEPH) is part of group 4 of the pulmonary hypertension (PH) classification and generally affects more than a third of patients referred to PH centers. It is a three-compartment disease involving proximal (lobar-to-segmental) and distal (subsegmental) pulmonary arteries that are obstructed by persistent fibrothrombotic material, and precapillary pulmonary arteries that can be affected as in pulmonary arterial hypertension. It is a rare complication of pulmonary embolism (PE), with an incidence of around 3% in PE survivors. The observed incidence of CTEPH in the general population is around six cases per million but could be three times higher than this, as estimated from PE incidence. However, a previous venous thromboembolic episode is not always documented. With advances in multimodality imaging and therapeutic management, survival for CTEPH has improved for both operable and inoperable patients. Advanced imaging with pulmonary angiography helps distinguish proximal from distal obstructive disease. However, right heart catheterization is of utmost importance to establish the diagnosis and hemodynamic severity of PH. The therapeutic strategy relies on a stepwise approach, starting with an operability assessment. Pulmonary endarterectomy (PEA), also known as pulmonary thromboendarterectomy, is the first-line treatment for operable patients. Growing experience and advances in surgical technique have enabled expansion of the distal limits of PEA and significant improvements in perioperative and mid- to long-term mortality. In patients who are inoperable or who have persistent/recurrent PH after PEA, medical therapy and/or balloon pulmonary angioplasty (BPA) are effective treatment options with favorable outcomes that are increasingly used. All treatment decisions should be made with a multidisciplinary team that includes a PEA surgeon, a BPA expert, and a chest radiologist.</p>\",\"PeriodicalId\":48985,\"journal\":{\"name\":\"Revista Portuguesa De Cardiologia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-06-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Portuguesa De Cardiologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.repc.2024.04.006\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Portuguesa De Cardiologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.repc.2024.04.006","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

慢性血栓栓塞性肺动脉高压(CTEPH)属于肺动脉高压(PH)分类的第 4 组,通常影响三分之一以上转诊至 PH 中心的患者。它是一种三腔疾病,涉及被持久性纤维血栓物质阻塞的近端(叶至节段)和远端(节段下)肺动脉,以及可能像肺动脉高压一样受影响的毛细血管前肺动脉。它是肺栓塞(PE)的一种罕见并发症,在 PE 存活者中的发病率约为 3%。在普通人群中,CTEPH 的观察发病率约为每百万人中有 6 例,但根据 PE 发病率估算,可能比这一数字高出三倍。然而,先前的静脉血栓栓塞发作并不总能被记录下来。随着多模式成像和治疗管理的进步,可手术和不可手术患者的 CTEPH 存活率都有所提高。先进的肺血管造影术有助于区分近端和远端阻塞性疾病。然而,右心导管检查对于确定 PH 的诊断和血液动力学严重程度至关重要。治疗策略采用循序渐进的方法,首先进行可手术性评估。肺动脉内膜切除术(PEA),又称肺血栓内膜切除术,是可手术患者的一线治疗方法。随着经验的积累和手术技术的进步,肺动脉内膜剥脱术的远端范围不断扩大,围手术期和中长期死亡率也有了显著改善。对于无法手术或 PEA 术后 PH 持续/复发的患者,药物治疗和/或球囊肺血管成形术(BPA)是有效的治疗方案,效果良好,越来越多地得到应用。所有治疗决定都应由一个多学科团队做出,该团队应包括一名 PEA 外科医生、一名 BPA 专家和一名胸部放射科医生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Chronic thromboembolic pulmonary hypertension: A comprehensive review of pathogenesis, diagnosis, and treatment strategies.

Chronic thromboembolic pulmonary hypertension (CTEPH) is part of group 4 of the pulmonary hypertension (PH) classification and generally affects more than a third of patients referred to PH centers. It is a three-compartment disease involving proximal (lobar-to-segmental) and distal (subsegmental) pulmonary arteries that are obstructed by persistent fibrothrombotic material, and precapillary pulmonary arteries that can be affected as in pulmonary arterial hypertension. It is a rare complication of pulmonary embolism (PE), with an incidence of around 3% in PE survivors. The observed incidence of CTEPH in the general population is around six cases per million but could be three times higher than this, as estimated from PE incidence. However, a previous venous thromboembolic episode is not always documented. With advances in multimodality imaging and therapeutic management, survival for CTEPH has improved for both operable and inoperable patients. Advanced imaging with pulmonary angiography helps distinguish proximal from distal obstructive disease. However, right heart catheterization is of utmost importance to establish the diagnosis and hemodynamic severity of PH. The therapeutic strategy relies on a stepwise approach, starting with an operability assessment. Pulmonary endarterectomy (PEA), also known as pulmonary thromboendarterectomy, is the first-line treatment for operable patients. Growing experience and advances in surgical technique have enabled expansion of the distal limits of PEA and significant improvements in perioperative and mid- to long-term mortality. In patients who are inoperable or who have persistent/recurrent PH after PEA, medical therapy and/or balloon pulmonary angioplasty (BPA) are effective treatment options with favorable outcomes that are increasingly used. All treatment decisions should be made with a multidisciplinary team that includes a PEA surgeon, a BPA expert, and a chest radiologist.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Revista Portuguesa De Cardiologia
Revista Portuguesa De Cardiologia CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.70
自引率
22.20%
发文量
205
审稿时长
54 days
期刊介绍: The Portuguese Journal of Cardiology, the official journal of the Portuguese Society of Cardiology, was founded in 1982 with the aim of keeping Portuguese cardiologists informed through the publication of scientific articles on areas such as arrhythmology and electrophysiology, cardiovascular surgery, intensive care, coronary artery disease, cardiovascular imaging, hypertension, heart failure and cardiovascular prevention. The Journal is a monthly publication with high standards of quality in terms of scientific content and production. Since 1999 it has been published in English as well as Portuguese, which has widened its readership abroad. It is distributed to all members of the Portuguese Societies of Cardiology, Internal Medicine, Pneumology and Cardiothoracic Surgery, as well as to leading non-Portuguese cardiologists and to virtually all cardiology societies worldwide. It has been referred in Medline since 1987.
期刊最新文献
Cardiovascular benefits of resistance exercise: It's time to prescribe. Cardio-oncology guidelines, structural heart disease and Kounis syndrome in the upcoming guidelines. Response to the letter "Cardio-oncology guidelines, structural heart disease and Kounis syndrome in the upcoming guidelines". Cardiac arrest: It is important not just to survive, but to survive with at least an acceptable quality of life. Diagnostic prediction rules in acute pulmonary embolism: Is it acceptable to compromise safety?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1